Publications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (16)

2026

  1. Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry

    Clinical and Translational Oncology, Vol. 28, Núm. 2, pp. 645-653

  2. Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

    Clinical and Translational Oncology, Vol. 28, Núm. 5, pp. 1807-1814

  3. Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)

    Clinical and Translational Oncology, Vol. 28, Núm. 1, pp. 320-329

  4. Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

    Clinical and Translational Oncology, Vol. 28, Núm. 6, pp. 2377-2385

2025

  1. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

    Clinical and Translational Oncology, Vol. 27, Núm. 1, pp. 386-391

  2. Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

    Melanoma Research, Vol. 35, Núm. 6, pp. 399-408

2024

  1. Access to melanoma drugs in Spain: a cross-sectional survey

    Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2572-2583

2023

  1. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

    Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775

2021

  1. Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy

    Journal of Healthcare Quality Research, Vol. 36, Núm. 3, pp. 142-149

2020

  1. Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

    Science Translational Medicine, Vol. 12, Núm. 565

2019

  1. A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1754-1762

  2. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

    Oncologist, Vol. 24, Núm. 10, pp. 1375-1383

2018

  1. Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

    Therapeutic Advances in Medical Oncology, Vol. 10

2016

  1. GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

    Annals of Oncology, Vol. 27, pp. vi383

2015

  1. Immune checkpoint inhibitors: Therapeutic advances in melanoma

    Annals of Translational Medicine, Vol. 3, Núm. 18

2002

  1. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160